DUAL-ACTING THROMBOXANE RECEPTOR ANTAGONIST SYNTHASE INHIBITORS - HETEROCYCLIC VARIATIONS

被引：7
|
作者：
FAULL, AW
GASKIN, H
HADFIELD, PS
JESSUP, R
RUSSELL, K
WATKINS, WJ
WAYNE, M
机构：
[1] ICI PHARMACEUT PLC,DEPT CHEM 2,MERESIDE,ALDERLEY PK,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND
[2] ICI PHARMACEUT PLC,DEPT BIOSCI 2,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1992年 / 2卷 / 10期
关键词：
D O I：
10.1016/S0960-894X(00)80210-3
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The ability of 1,3-dioxanes bearing a variety of aromatic heterocycles at C4 to inhibit thromboxane synthase has been examined. Potent dual-acting thromboxane receptor antagonist/thromboxane synthase inhibitors have been discovered.
引用
收藏
页码：1181 / 1186
页数：6
相关论文
共 50 条
  • [41] Pharmacokinetics, excretion and metabolites analysis of DL0410, a dual-acting cholinesterase inhibitor and histamine-3 receptor antagonist
    Pang, Xiaocong
    Zhao, Ying
    Song, Junke
    Kang, De
    Wu, Song
    Wang, Lin
    Liu, Ailin
    Du, Guanhua
    MOLECULAR MEDICINE REPORTS, 2019, 20 (02) : 1103 - 1112
  • [42] Ridogrel, a dual thromboxane synthase inhibitor and receptor antagonist: anti-inflammatory profile in inflammatory bowel disease
    Carty, E
    Macey, M
    Mccartney, SA
    Rampton, DS
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (06) : 807 - 817
  • [43] Pharmacological evaluation of BM-573 an original dual thromboxane receptor antagonist and thromboxane synthase inhibitor as novel potent antithrombotic agent.
    Dogné, JMPN
    de Leval, X
    Benoit, P
    Neven, P
    de Leval, L
    Rolin, S
    David, JL
    Masereel, B
    BLOOD, 2001, 98 (11) : 42A - 42A
  • [44] G-619, A DUAL THROMBOXANE SYNTHASE INHIBITOR AND THROMBOXANE A(2) RECEPTOR ANTAGONIST, INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA BIOSYNTHESIS
    ALTAVILLA, D
    SQUADRITO, F
    CANALE, P
    IOCULANO, M
    SQUADRITO, G
    CAMPO, GM
    SERRANO, M
    SARDELLA, A
    URNA, G
    SPIGNOLI, G
    CAPUTI, AP
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 286 (01) : 31 - 39
  • [45] PHARMACOLOGICAL CHARACTERIZATION OF CINNAMOPHILIN, A NOVEL DUAL INHIBITOR OF THROMBOXANE SYNTHASE AND THROMBOXANE A(2) RECEPTOR
    YU, SM
    WU, TS
    TENG, CM
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 111 (03) : 906 - 912
  • [46] Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition.: 3.: Synthesis and biological activities of oxazolecarboxamide-substituted ω-phenyl-ω-(3-pyridyl)alkenoic acid derivatives and related compounds
    Takeuchi, K
    Kohn, TJ
    True, TA
    Mais, DE
    Wikel, JH
    Utterback, BG
    Wyss, VL
    Jakubowski, JA
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (27) : 5362 - 5374
  • [47] Pharmacological and Toxicological Screening of Novel Benzimidazole-Morpholine Derivatives as Dual-Acting Inhibitors
    Can, Nafiz Oncu
    Cevik, Ulviye Acar
    Saglik, Begum Nurpelin
    Ozkay, Yusuf
    Atli, Ozlem
    Baysal, Merve
    Ozkay, Ulmide Demir
    Can, Ozgur Devrim
    MOLECULES, 2017, 22 (08)
  • [48] Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor
    Dogné, JM
    Wouters, J
    Rolin, S
    Michaux, C
    Pochet, L
    Durant, F
    Delarge, J
    Masereel, B
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (05) : 669 - 680
  • [49] INVITRO CHARACTERIZATION OF CGS 22652 - A COMBINED THROMBOXANE RECEPTOR ANTAGONIST (TXRA) THROMBOXANE SYNTHASE INHIBITOR (TXSI)
    COHEN, DS
    BHAGWAT, S
    DOTSON, R
    MATHIS, J
    FURNESS, P
    LOUZAN, M
    LEE, W
    PEPPARD, J
    GUDE, C
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1077 - 1077
  • [50] Activity of a novel dual thromboxane A2 receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles
    Rolin, S
    Dogné, JM
    Michaux, C
    Delarge, J
    Masereel, B
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2001, 65 (02): : 67 - 72
12345